Vaccinex Stock Price - VCNX

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
CHART Trader
Monthly Subscription
for only
$30.66
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Vaccinex Inc VCNX NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.05 -0.83% 5.97 6.07 5.97 6.07 6.02 09:45:04
Bid Price Ask Price Spread Spread % News
5.97 6.22 0.25 4.02% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3 103 $ 5.97 $ 615 7,907 3.32 - 8.49
Last Trade Time Type Quantity Stock Price Currency
09:36:35 100 $ 5.97 USD

Vaccinex Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 88.73M 14.86M $ -29.52M -1.43 - 14.66M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 4.00 1.40%

more financials information »

Vaccinex News

Date Time Source News Article
10/09/201906:01Edgar (US Regulatory)Notice of Effectiveness (effect)
10/04/201911:36Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)
10/04/201911:23Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)
10/04/201910:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
10/04/201910:57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
10/02/201908:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
10/02/201908:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)

Latest VCNX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VCNX Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week6.656.885.736.08872k-0.68-10.23%
1 Month67.975.637.336310k-0.03-0.50%
3 Months4.127.973.946.24096k1.8544.90%
6 Months6.258.493.946.02378k-0.28-4.48%
1 Year6.188.493.325.73238k-0.21-3.40%
3 Years12123.328.100014k-6.03-50.25%
5 Years12123.328.100014k-6.03-50.25%

Vaccinex Description

Vaccinex Inc is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead platform technologies include SEMA4D antibody platform and ActivMAb antibody discovery platform. Its lead product candidate VX15 is in clinical development for the treatment of NSCLC, osteosarcoma and Huntington's disease and additional product candidates VX5 and VX25 are in earlier stages of development.
Your Recent History
NASDAQ
VCNX
Vaccinex
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191014 14:03:59